Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

SkinBioTherapeutics PLC

SBTX.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Biotechnology & Medical Research ·

UK Micro Cap Analyst: BUY

Last Close

$0.13

▼ -3.66%

Market Cap $34.51M · Vol 405.98K

Key Metrics

P/E Ratio

N/A

FWD: 79.13

Market Cap

$34.51M

Micro Cap

Div Yield

N/A

EPS Growth

+100.00%

YoY

RSI (14)

0.00

Momentum

Beta

0.45

vs Market

52W High

$0.31

56.84% below

52W Low

$0.07

99.00% above

Volume

405.98K

Avg 418.45K

P/B

4.62

Price-to-book

ROE

N/A

Return on equity

Free Float

58.80%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, SkinBioTherapeutics PLC (SBTX.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SBTX.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.22%

+1.28%

-20.20%

YTD

-37.30%

-29.46%

-47.41%

-84.69%

Financials & Valuation

TTM · Annual

Total Revenue	$6.37M
Net Income	$-956,164.00
Revenue Growth (YoY)	+37.39%
Gross Margin	61.65%
Operating Margin	-24.22%
Net Profit Margin	-15.01%
ROE	N/A
ROA · ROIC	-8.25% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	79.13
PEG Ratio	N/A
P/S	8.25
P/B	4.62
P/FCF	N/A
EPS Growth	+100.00%
Outstanding Shares	259.17M

Technical Indicators

50-Day SMA	$0.14
200-Day SMA	$0.17
RSI (14)	0.00
Beta	0.45
52-Week High	$0.31
52-Week Low	$0.07

Volume Today	405.98K
Avg Daily Volume (30D)	418.45K
Relative Volume	0.97x
Volatility (10D)	35.51
Volatility (30D)	48.68
Free Float	58.80%

Analyst Consensus

BUY

Current Price $0.13

Mean Target $0.39

52W Low$0.07 52W High$0.31

Current

Target

$0.07 $0.31

Current Analyst target

+192.00% upside potential · 1 analysts

Identifiers

ExchangeLSE

FIGIBBG00G99XT32

ISINGB00BF33H870

CountryUnited Kingdom

Sub-IndustryBio Therapeutic Drugs

Earnings DateDec 3, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

SkinBioTherapeutics plc is a United Kingdom-based life science company focused on skin health. The principal activity of the Company is that of research and development focused on harnessing the microbiome for human health, and commercialization of these technologies, as well as the manufacture and sales of dermatological products through acquired entities. Its segments include UK, US, EU, and RoW. Its platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. It targets five specific skin healthcare sectors, such as cosmetics skincare, food supplements for the treatment of skin conditions, medical skin care, infection control in both the home and the hospital environment and pharmaceuticals for the prescribed treatment of skin conditions. Its first product, AxisBiotix-Ps, is a food supplement to address the symptoms of mild to moderate psoriasis-a chronic inflammatory condition of the skin.